News: IMM Immutep Receives Positive EMA Scientific Advice For Further Clinical Development Of EFTI..., page-22

If data is good (just good, statistically significant, not at all miraculously good), this being passing Ph II/b, the "bottle neck phase", into Ph III, it will not matter what Mr Market will think as it will be about what big guns in the game will think which will DRIVE the market. It will be a game for them to play out, hopefully partnership, not for a few daytradwrs & shorters to play the market with the small floating portion of the registry (making the reasonable assumption that most quick profit makers have by now sold their cheaply bought shates).

So, even if I were a short term, or day trader, I would NOT immediately sell on good AIPAC news. I would wait to hear of the big guns taking interest.